CVE-2026-108471Windows Virtualization-Based Security (VBS) Enclave Elevation of Privilege Vulnerability
Updated under an hour ago ()
Does this affect you?
It affects Microsoft Windows 10 Version 1809 and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.33%, higher than 25% of scored CVEs.
Do this next
Free account, 1 product
Untrusted pointer dereference in Windows Virtualization-Based Security (VBS) Enclave allows an authorized attacker to elevate privileges locally.
- CVSS
- 8.8 HIGH (v3.1, CNA)CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H/E:U/RL:O/RC:C
- Weakness (CWE)
- CWE-184
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.33% (percentile 25)
- Assigned by
- microsoft
- NVD analysis
- Awaiting Analysis
- Record last updated
- Oct 16, 2026
- First seen by InfoSec Signals
- Oct 13, 2026
Affected products
Microsoft Windows 10 Version 1809 microsoft:windows_10_1809 | from 10.0.17763.0 before 10.0.17763.9376 | CNA record |
Microsoft Windows Server 2019 microsoft:windows_server_2019 (from the name) | from 10.0.17763.0 before 10.0.17763.9376 | CNA record |
References
- https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-108471vendor-advisory, patch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.